A colonic biomarker of Parkinson's disease?

Movement Disorders

Volumn 27, Issue 6, 2012, Pages 674-676

  Olanow, C Warren ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; ALPHA SYNUCLEIN; BIOLOGICAL MARKER;

DISEASE COURSE; EDITORIAL; HELICOBACTER INFECTION; HUMAN; LEWY BODY; MOTONEURON; MYENTERIC PLEXUS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; SIGMOID; UPPER GASTROINTESTINAL TRACT;

ALPHA-SYNUCLEIN; COLON; ENTERIC NERVOUS SYSTEM; FEMALE; HUMANS; MALE; NEURONS; PARKINSON DISEASE;

EID: 84861670648     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25067     Document Type: Editorial

References (20)

1. Shannon KM, Keshavarzian A, Ultlu E et al. Alpha-synuclein in colonic submucosa in early untreated Parkinson disease. Mov Disord 2012; 27: 709-715.
2. Shannon KM, Keshavarzian A, Dodiya H et al. Is alpha-synuclein in the colon a biomarker for premotor Parkinson disease? Evidence from 3 cases. Mov Disord 2012; 27: 716-719.
3. Jellinger KA. Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts. Mov Disord 2012; 27: 8-30.
4. Wakabayashi K, Takahashi H, Takeda S, et al. Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses. Acta Neuropathol 1988; 76: 217-221.
5. Braak H, de Vos KA, Bohl J, Del Tredici KG. Gastric alpha synuclein reactive inclusions in Meissners and Auerbach's plexuses in cases staged for Parkinson's disease related brain pathology. Neurosci Lett 2006; 396: 67-72.
6. Pouclet H, Lebouvier T, Coron E, et al. Lewy pathology in gastric and duodenal biopsies in PD. Mov Disord 2012; 27: 708.
7. Lebouvier T, Neunlist M, Bruley des Varannes S, et al. Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms. PLOS One 2010; 5: e12728.
8. Pouclet H, Lebouvier T, Coron E, et al. A comparison between rectal and colonic biopsies to detect Lewy pathology in Parkinson's disease. Neurobiol Dis 2012; 45: 305-309.
9. Beach, TG, Adler CH, Sue LI, et al. Multi-organ distribution of phophorylated α-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol 2010; 119: 689-702.
10. Braak H, Del Tredici K, Rüb U, et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003; 24: 197-211.
11. Abbott RD, Petrovitch H, White LR, et al. Frequency of bowel movements and the future risk of Parkinson's disease. Neurology 2001; 57: 456-462.
12. Strang RR. The association of gastro-duodenal ulceration and Parkinson's disease. Med J Aust 1965; 1: 842-843.
13. Weller C, Oxlade N, Dobbs SM, et al. Role of inflammation in gastrointestinal tract in aetiology and pathogenesis of idiopathic parkinsonism. FEMS Immunol Med Microbiol 2005; 44: 129-135.
14. Hawkes CH, Del Tredici K, Braak H. Parkinson's disease: a dual-hit hypothesis [review]. Neuropathol Applied Neurobiol 2007; 33: 599-614.
15. Olanow CW, Prusiner SB. Is Parkinson's disease a prion disorder. Proc Natl Acad Sci U S A 2009; 106: 12571-12572.
16. Desplats P, Lee HJ, Bae EJ, et al. Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc Natl Acad Sci U S A 2009; 106: 13010-13015.
17. Hansen C, Angot E, Bergstrom AL, et al. α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells. J Clin Invest 2011; 121: 715-725.
18. Volpicelli-Daley LA, Luk KC, Patel TP, et al. Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 2011; 72: 52-71.
19. Miwa H, Kubo T, Suzuki A, et al. Intragastric proteasome inhibition induces alpha-synuclein-immunopositive aggregations in DMN neurons in the rats. Neurosci Lett 2006; 401: 146-149.
20. Ravina B, Eidelberg D, Ahlskog JE, et al. The role of radiotracer imaging in Parkinson disease. Neurology 2005; 64: 208-215.